Clinical Trial Results: Positive results often lead to price increases, while negative results can cause significant drops.

Regulatory Approvals: FDA approval or rejection of SLRX's drugs heavily influences investor confidence and stock value.

Competitor Activity: Developments in competing therapies can impact SLRX's market position and stock price.

Market Sentiment: Overall investor optimism or pessimism in the biotechnology sector affects SLRX's valuation.

Financial Performance: Revenue, earnings, and cash flow reports directly impact investor perception of SLRX's stability.

Partnerships & Acquisitions: Strategic alliances or acquisitions can boost investor confidence and the stock price.

Debt Levels: High debt can raise concerns about financial stability, potentially lowering the stock price.

Economic Conditions: Broader economic trends can influence investment in riskier assets like biotech stocks.

Management Changes: Changes in leadership can impact investor confidence and influence the stock's performance.